Boehringer to Settle Lawsuits for $650 Million

02.06.2014 - German drugmaker Boehringer Ingelheim has said it will pay about $650 million to settle US lawsuits that claimed the company's blockbuster blood thinner, Pradaxa (dabigatran)...